This week, we officially launched the International Transplantation Science Meeting 2025, a global collaboration between the American Society of Transplantation, The Transplantation Society, and the European Society for Organ Transplantation. The meeting brings together leading researchers, clinicians, and innovators to explore cutting-edge advances in organ transplantation.
🔬 Opening Lecture: Ex Vivo Lung Perfusion
Dr. Marcelo Cypel from the Toronto Lung Transplant Program shared his team experience with >1,000 ex vivo lung perfusions (EVLPs), a remarkable achievement that has significantly expanded the use of marginal lung donors.
The EVLP platform integrates imaging, physiology, transcriptomics, proteomics, and metabolomics to generate a comprehensive profile of each donor organ. Dr. Cypel’s team is now leveraging AI-driven algorithms to predict graft suitability, with a randomized clinical trial currently underway. This approach has the potential to transform how lungs are evaluated and selected for transplantation worldwide.
🤖 Artificial Intelligence in Transplantation: A Visionary Framework
Following that, Dr. Khodor Abou-Daya delivered a forward-looking talk on the transformative role of AI in transplantation.
He emphasized that while the human brain cannot process millions of data points simultaneously, AI can extract patterns and insights from high-dimensional datasets. Dr. Abou-Daya introduced SATURN, a universal cell embedding framework that integrates transcriptomic, histologic, and imaging data into unified representation, laying the groundwork for predictive analytics in transplant science.
He also discussed the Scientists’ AI initiative, launched by AI pioneer Yoshua Bengio. Unlike traditional AI models, which are often optimized to generate pleasing but occasionally misleading outputs, this initiative seeks to build honest, explainable, and justifiable AI systems = more reliable and rational research.
🧠Looking Ahead: Key Questions at the Intersection of AI and Transplantation
These groundbreaking presentations raise essential questions for the field:
Can AI help us better match donors to recipients?
Should AI models be regulated like medical devices, despite their continuous evolution?
Could AI optimize our use of anti-rejection therapies by integrating clinical, molecular, and pharmacologic data?
How do we ensure reproducibility, transparency, and ethics in AI-guided transplant decisions?
As these conversations continue, it’s clear we’re only at the beginning of a major transformation.
🙌 Acknowledgment: This event would not have been possible without the commitment and scientific leadership of an outstanding planning committee.
Dr. Jonathan Bromberg, University of Maryland
Dr. Fadi Issa, University of Oxford
Dr. Xunrong Luo, Duke University
Dr. William Scott, Newcastle University
Dr. Maria Kaisar, University of Oxford
Stay tuned #ITS2025.